Elite Pharmaceuticals, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $311.24K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $77.06K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $42.22K, a 88.99% decline year-over-year.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $83.10K, a 69.62% decline year-over-year.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2025 was $19.30K, a 95.79% decline from fiscal 2024.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2024 was $458.99K, a 495.61% increase from fiscal 2023.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2023 was $77.06K.
- Elite Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2021 was $42.22K, a 97.06% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-03-31 | $19.30K 10-K · filed 2026-06-29 | |
| 2024-03-31 | $458.99K 10-K · filed 2025-06-30 | |
| 2023-12-31 | $311.24K 10-Q · filed 2025-02-13 | |
| 2023-03-31 | $77.06K 10-K · filed 2024-07-01 | |
| 2022-09-30 | $77.06K 10-Q · filed 2024-02-14 | |
| 2021-03-31 | $42.22K 10-K · filed 2022-06-29 | |
| 2020-09-30 | $42.22K 10-Q · filed 2022-02-14 | |
| 2020-03-31 | $1.44M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $83.10K 10-Q · filed 2021-02-16 | $1.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $383.59K 10-Q · filed 2021-02-16 | $1.39M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $340.30K 10-Q · filed 2021-02-16 | $2.24M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $393.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $2.06M 10-K · filed 2020-06-29 |
| 2018-12-31 | $273.55K 10-Q · filed 2020-02-10 | $2.46M derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-09-30 | $1.23M 10-Q · filed 2020-02-10 | $2.44M derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-06-30 | $168.17K 10-Q · filed 2020-02-10 | $1.74M derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-03-31 | $791.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $2.00M 10-K · filed 2019-06-21 |
| 2017-12-31 | $252.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-09 | $3.03M derived: sum of 4 quarters · filed 2018-06-14 |
| 2017-09-30 | $531.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $4.02M derived: sum of 4 quarters · filed 2018-06-14 |
| 2017-06-30 | $423.77K 10-Q · filed 2017-08-09 | $5.55M derived: sum of 4 quarters · filed 2018-06-14 |
| 2017-03-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-14 | $7.59M 10-K · filed 2018-06-14 |
| 2016-12-31 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | $8.68M derived: sum of 4 quarters · filed 2018-06-14 |
| 2016-09-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-09 | $7.95M derived: sum of 4 quarters · filed 2018-06-14 |
| 2016-06-30 | $2.47M 10-Q · filed 2016-08-09 | $6.63M derived: sum of 4 quarters · filed 2018-06-14 |
| 2016-03-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-14 | $6.20M 10-K · filed 2018-06-14 |
| 2015-12-31 | $509.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-09 | $6.85M derived: sum of 4 quarters · filed 2017-06-14 |
| 2015-09-30 | $739.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-30 | $9.79M derived: sum of 4 quarters · filed 2017-06-14 |
| 2015-06-30 | $2.04M 10-Q · filed 2015-12-30 | $14.38M derived: sum of 4 quarters · filed 2017-06-14 |
| 2015-03-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-14 | $13.24M 10-K · filed 2017-06-14 |
| 2014-12-31 | $3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | $16.17M derived: sum of 4 quarters · filed 2016-06-15 |
| 2014-09-30 | $5.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-14 | $14.33M derived: sum of 4 quarters · filed 2016-06-15 |
| 2014-06-30 | $896.61K 10-Q · filed 2014-08-14 | $10.50M derived: sum of 4 quarters · filed 2016-06-15 |
| 2014-03-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-15 | $10.00M 10-K · filed 2016-06-15 |
| 2013-12-31 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | |
| 2013-09-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-14 | |
| 2013-06-30 | $400.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 |